Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore‐Bianchi, Alberto Bardelli, Alice Bartolini et al.|Nature Medicine|2022Cited by 259
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerMargherita Ambrosini, Filippo Pietrantonio, Benoı̂t Rousseau et al.|Annals of Oncology|2024Cited by 73
Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancerPaolo Manca, Francisco Sánchez-Vega, Chin‐Tung Chen et al.|npj Precision Oncology|2025Cited by 4